Masimo Corporation

NASDAQ:MASI

Medical - Devices

Healthcare
$179.95 +0.00%

+$0.00 today

Market cap
$9.42B
Beta
1.10
P/E (TTM)
123.1
EPS (TTM)
$1.46
52W Low $125.94High $179.99

Volume 0.00M

Average 1.08M

MASI Operating Cash Flow

Cash generated by the company's core business operations during the period.

Masimo CorporationNASDAQ: MASI

Operating Cash Flow · Q1 FY2026 · quarter ended Apr 2026

Operating cash flow growth accelerates

Q1 FY2026 operating cash flow of $45.3M rose 45.7% year over year, ahead of the +27.7% change in trailing-twelve-month operating cash flow. Sequentially, it fell 25.1% from the prior quarter. Over 3 fiscal years it compounded at +94.8% a year.

Context

  • Operating cash flow amounted to 14.2% of revenue in FY2025, up 4.8 pp from a year earlier.
  • Operating cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +45.7% holds above the trailing-twelve-month pace of +27.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
$45.3M-25.1% QoQ
Last fiscal yearJan 2026
$217.2M+10.6% YoY
LTMApr 2026
$232M+27.7% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+45.7%——
1 year+10.6%——
3-year CAGR+94.8%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
217.2M USD
Year-over-year change
+10.6%
4-year CAGR
-4.8%

Operating Cash Flow vs competitors

How MASI compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +27.7% is the 4th highest of 11, against a peer median of -2.1%.
  • Operating cash flow amounts to 14.9% of revenue for MASI, versus a peer median of 14.8%.
MASI Competitors
Operating Cash Flow for MASI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAXBaxter International Inc.LTM Jun 2026$1.32B USD+72.4%-11.3%11.5%
HSICHenry Schein, Inc.LTM Jun 2026$700M USD+36.7%+5.8%5.1%
AVTRAvantor, Inc.LTM Jun 2026$597M USD-12.4%-9.6%9.1%
ATRAptarGroup, Inc.LTM Jun 2026$583.48M USD-5.3%+6.0%14.8%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$492.6M USD-7.8%+39.9%19.0%
MOHMolina Healthcare, Inc.LTM Sep 2026$331M USD+171.8%—0.8%
STVNStevanato Group S.p.A.LTM Jun 2026€247.03M EUR-17.8%+38.6%20.2%
MASIMasimo CorporationLTM Apr 2026$232M USD+27.7%+94.8%14.9%
ABVXAbivax S.A.FY2025€155.69M EUR+1.1%+42.4%—
RGENRepligen CorporationLTM Jun 2026$134.86M USD+2.1%-12.0%17.2%
RYTMRhythm Pharmaceuticals, Inc.LTM Sep 2026$81.79M USD-25.1%-12.6%29.1%
Peer median (excluding MASI) —-2.1%+5.8%14.8%

Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Net Income229.6M143.5M81.5M(304.9M)(151.5M)
Depreciation & Amortization35.6M136.1M98.3M103M38.8M
Deferred Income Tax(15.1M)(39.3M)(35.6M)(38.2M)11.8M
Stock-Based Compensation44.7M47.7M7M41.5M35.8M
Change in Working Capital(31.5M)(261.8M)(70.9M)(10.7M)(89.9M)
Accounts Receivables(76.9M)(151.3M)91.9M(60.2M)17.2M
Inventory13.5M(155.9M)(69.2M)(7.5M)(112.1M)
Accounts Payables11M60.5M(19.6M)14.8M(27.1M)
Other Working Capital20.9M(15.1M)(74M)42.2M32.1M
Other Non-Cash Items1.3M3.2M13.8M405.7M372.2M
Operating Cash Flow264.6M29.4M94.1M196.4M217.2M
Capital Expenditures(34.9M)(56.3M)(87.7M)(51.1M)(19.4M)
Acquisitions (Net)0(999.7M)7.5M00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(12M)(5.2M)(44.7M)(31.2M)294.5M
Investing Cash Flow(37.5M)(1.06B)(81.2M)(51.2M)275.1M
Debt Repayment0939.2M(51.2M)(146.8M)(207.8M)
Common Stock Issued23.2M8.1M7M25.2M71.4M
Common Stock Repurchased(128.9M)(401.5M)00(363.7M)
Dividends Paid00000
Other Financing Activities(16.7M)(25.4M)(12.9M)(4M)(20.6M)
Financing Cash Flow(122.4M)520.4M(57.1M)(125.6M)(520.7M)
Effect of Forex Changes(1.3M)(30.9M)2.8M(6.4M)53.8M
Net Change in Cash103.4M(538.8M)(41.4M)13.2M26M
Free Cash Flow229.7M(26.9M)6.4M145.3M197.8M

Masimo Corporation

NASDAQ:MASI

Intrinsic Alpha fair value

Locked

Current Price

$179.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.